Pulse Entdecken nav.journalClub Debatten Trends Forschende Zeitschriften

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure | Synapse

May 9, 2026

View Full Paper

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure

ZCZachary L. CoxHeart Failure / Cardiomyopathy SCSean P. CollinsRutgers, The State University of New Jersey GHGabriel A. HernandezHeart Failure / Cardiomyopathy

Key Points

Key points are not available for this paper at this time.

KI fragen

Like

Bookmark

Share

View Full Paper

KI fragen

Like

Bookmark

Share

View Full Paper

Cite This Study

Cox et al. (Mon,) studied this question.

synapsesocial.com/papers/69fefc0101f2661b39363e8a https://doi.org/https://doi.org/10.1016/j.jacc.2024.02.009

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction2019 · 6,991 citations
2Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline2022 · 283 citations
3Similarities and Distinctions Between Acetazolamide and Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Acute Heart Failure: Key Insights Into ADVOR and EMPULSE2023 · 14 citations
4Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics2023 · 101 citations
5New Decongestion Strategies in an Evolving Heart Failure Landscape2022 · 8 citations